Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients

BACKGROUND: To investigate a possible role of Cefditoren, a recently marketed in Greece third-generation oral cephalosporin in urinary infections of outpatients. METHODS: During a multicenter survey of Enterobacteriaceae causing UTIs in outpatients during 2005–2007, Cefditoren MICs were determined b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hatzaki, Despina, Poulakou, Garyphallia, Katsarolis, Ioannis, Lambri, Niki, Souli, Maria, Deliolanis, Ioannis, Nikolopoulos, Georgios K, Lebessi, Evangelia, Giamarellou, Helen
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3518207/
https://ncbi.nlm.nih.gov/pubmed/23009290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-228
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars